News | December 19, 2025
Takeda joins BaseLaunch to boost early-stage biotech ventures in Europe
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
Further strengthens BaseLaunch's global pharma industry partnerships
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk
Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
The trial met its primary endpoint, with patients receiving povetacicept achieving a 52.0% reduction in UPCR at Week 36
The company announced positive topline data from the Phase II ZUPREME-1 trial
Subscribe To Our Newsletter & Stay Updated
